ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,782.98
0.28%
Gold vs US Dollar
2,327.36
1.46%
Brent Oil
83.51
0.46%
Bitcoin
64,053.99
0.09%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Applied DNA Sciences Inc (APDN)

  7. Applied DNA Sciences Inc (APDN) News

Applied DNA Sciences (APDN)

Applied DNA Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APDN
DateTimeSourceHeadlineSymbolCompany
04/03/202422:18Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:APDNApplied DNA Sciences Inc
12/02/202421:25Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:APDNApplied DNA Sciences Inc
12/02/202421:09Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:APDNApplied DNA Sciences Inc
08/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
08/02/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APDNApplied DNA Sciences Inc
01/02/202421:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:APDNApplied DNA Sciences Inc
26/01/202421:24Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:APDNApplied DNA Sciences Inc
10/01/202422:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APDNApplied DNA Sciences Inc
08/01/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
05/01/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
07/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
07/12/202321:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:APDNApplied DNA Sciences Inc
06/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
07/11/202322:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
07/11/202322:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:APDNApplied DNA Sciences Inc
20/09/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
10/08/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
10/08/202321:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APDNApplied DNA Sciences Inc
01/08/202321:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
13/07/202322:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
07/06/202311:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APDNApplied DNA Sciences Inc
11/05/202321:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APDNApplied DNA Sciences Inc
05/05/202321:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APDNApplied DNA Sciences Inc
03/05/202320:00Business WireApplied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023NASDAQ:APDNApplied DNA Sciences Inc
07/04/202317:00Business WireApplied DNA's CertainT® Supply Chain Traceability Platform Featured in New York Times Article About the Need for Transparency and Compliance in Global Supply Chains Under Recently Passed U.S. Federal RegulationNASDAQ:APDNApplied DNA Sciences Inc
29/03/202314:00Business WireApplied DNA Achieves Milestone for Large-Scale linearDNA™ Production, Delivers Largest Single Shipment by Volume to DateNASDAQ:APDNApplied DNA Sciences Inc
28/03/202311:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APDNApplied DNA Sciences Inc
22/03/202313:35Business WireApplied DNA Submits Validation Package to New York State Department of Health for Approval of Pharmacogenomic (PGx) AssayNASDAQ:APDNApplied DNA Sciences Inc
14/02/202315:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APDNApplied DNA Sciences Inc
10/02/202314:34Business WireApplied DNA Announces New York State Award Valued at Up To $1.5 Million to Support Establishment of cGMP linearDNA™ Production Capacity on Long Island, New YorkNASDAQ:APDNApplied DNA Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:APDN

Your Recent History

LSE
POS
Plexus
LSE
RR.
Rolls-royce
LSE
SBTX
Skinbiotherapeutics
LSE
SRSP
Sirius Petroleum
LSE
HUM
Hummingbird Resources
LSE
AAU
Ariana Resources
LSE
BIRD
Blackbird
LSE
SCE
Surface Transforms
LSE
AGL
Angle
LSE
LLOY
Lloyds Banking
LSE
ENET
Ethernity Networks
LSE
SOLG
Solgold
LSE
GFM
Griffin Mining
LSE
OBI
Ondine Biomedical
LSE
SCLP
Scancell
LSE
INSG
Insig Ai
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved